아센디스 파마 A/S

SecurityASND / Ascendis Pharma A/S
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership189,027 shares
Latest Disclosed Value $ 43,236,146
Millennium Management Llc ownership in ASND / Ascendis Pharma A/S

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 189,027 shares of Ascendis Pharma A/S (US:ASND) valued at $43,236,146 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 262,329 shares of Ascendis Pharma A/S. This represents a change in shares of -27.94% during the quarter. The current value of the position is $39,780,732 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (ASND) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ASND / Ascendis Pharma A/S Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 189,027 -73,302 -27.94 43,236 -22.71 0.0180
2026-02-17 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 262,329 87,726 50.24 55,939 61.15 0.0235
2025-11-14 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 174,603 101,715 139.55 34,713 175.93 0.0148
2025-08-14 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 72,888 -191,979 -72.48 12,580 -69.53 0.0061
2025-05-15 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 264,867 -93,277 -26.04 41,282 -16.27 0.0220
2025-02-14 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 358,144 -143,546 -28.61 49,306 -34.18 0.0241
2024-11-14 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 501,690 28,241 5.96 74,907 16.01 0.0355
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 473,449 111,389 30.77 64,569 17.97 0.0299
2024-05-15 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 362,060 339,669 1,516.99 54,733 1,840.85 0.0234
2024-02-14 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 22,391 -20,461 -47.75 2,820 -29.71 0.0012
2023-11-14 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 42,852 42,852 4,013 0.0020
2023-05-15 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -7,524 -100.00 0 -100.00
2023-02-14 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 7,524 -19,009 -71.64 919 -66.46 0.0005
2022-11-14 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 26,533 -38,390 -59.13 2,740 -54.60 0.0016
2022-08-15 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 64,923 -92,241 -58.69 6,035 -67.28 0.0037
2022-05-16 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 157,164 31,568 25.13 18,445 9.17 0.0098
2022-02-14 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 125,596 -58,788 -31.88 16,896 -42.51 0.0086
2021-11-15 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 184,384 175,906 2,074.85 29,389 2,535.78 0.0176
2021-08-16 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 8,478 -60,532 -87.71 1,115 -87.46 0.0007
2021-05-17 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 69,010 -16,981 -19.75 8,894 -37.99 0.0064
2021-02-16 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 85,991 -35,347 -29.13 14,342 -23.41 0.0104
2020-11-16 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 121,338 -86,280 -41.56 18,725 -39.02 0.0231
2020-08-14 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 207,618 -62,459 -23.13 30,707 0.97 0.0421
2020-05-14 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 270,077 -218,685 -44.74 30,413 -55.27 0.0683
2020-02-14 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 488,762 -521,581 -51.62 67,997 -30.13 0.0851
2019-11-14 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,010,343 -106,611 -9.54 97,316 -24.34 0.1538
2019-08-15 2019-06-30 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,116,954 -261,355 -18.96 128,617 -20.72 0.1934
2019-08-14 2019-06-30 13F RENASANT COM 04351P101 27,176 -1,367,689 1,042
2019-05-14 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,378,309 1,194,634 650.41 162,227 1,309.81 0.2428
2019-02-15 2018-12-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 183,675 -32,379 -14.99 11,507 -24.84 0.0179
2019-02-14 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 183,675 11,507
2018-11-14 2018-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 216,054 -351,169 -61.91 15,310 -59.42 0.0188
2018-08-14 2018-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 567,223 -98,504 -14.80 37,732 -13.34 0.0492
2018-05-15 2018-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 665,727 134,936 25.42 43,539 104.76 0.0581
2018-02-14 2017-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 530,791 18,377 3.59 21,263 14.47 0.0293
2017-11-14 2017-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 512,414 293,473 134.04 18,575 205.61 0.0283
2017-08-14 2017-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 218,941 80,558 58.21 6,078 56.85 0.0108
2017-05-15 2017-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 138,383 -88,421 -38.99 3,875 -15.60 0.0071
2017-02-14 2016-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 226,804 150,582 197.56 4,591 199.67 0.0096
2016-11-14 2016-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 76,222 76,222 0.00 1,532 0.0026
2015-11-16 2015-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -21,384 -100.00 0 -100.00
2015-08-14 2015-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 21,384 -31,737 -59.74 378 -59.00 0.0007
2015-05-15 2015-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 53,121 53,121 922 0.0017
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 2,500 -89.13 533 -88.34 n/a n/a n/a
2025-11-14 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 23,000 4,573 n/a n/a n/a
2025-08-14 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 5,000 779 n/a n/a n/a
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 75,000 11,338 n/a n/a n/a
2023-02-14 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 36,200 3.43 3,738 14.87 n/a n/a n/a
2022-08-15 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 35,000 -30.00 3,254 -44.55 n/a n/a n/a
2022-05-16 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 50,000 233.33 5,868 190.78 n/a n/a n/a
2022-02-14 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 15,000 0.00 2,018 -15.60 n/a n/a n/a
2021-11-15 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 15,000 -57.14 2,391 -48.07 n/a n/a n/a
2021-08-16 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 35,000 316.67 4,604 325.12 n/a n/a n/a
2021-05-17 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 8,400 -84.36 1,083 -87.91 n/a n/a n/a
2021-02-16 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 53,700 8,956 n/a n/a n/a
2020-11-16 2020-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR Call 46,400 6,863 n/a n/a n/a
2020-02-14 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR Call 10,900 -19.26 1,049 -32.54 n/a n/a n/a
2019-08-15 2019-06-30 13F/A ASCENDIS PHARMA A S SPONSORED ADR Call 13,500 -93.05 1,555 -93.20 n/a n/a n/a
2019-05-14 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR Call 194,200 22,857 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 20,000 3,976 n/a n/a n/a
2025-08-14 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 10,000 1,559 n/a n/a n/a
2025-02-14 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 38,000 5,674 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.